Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by {gamma}-carboxylation-dependent and -independent mechanisms.
暂无分享,去创建一个
[1] D. Howie,et al. The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles. , 2009, Biomaterials.
[2] A. Evdokiou,et al. Pro‐Inflammatory Cytokines TNF‐Related Weak Inducer of Apoptosis (TWEAK) and TNFα Induce the Mitogen‐Activated Protein Kinase (MAPK)‐Dependent Expression of Sclerostin in Human Osteoblasts , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] T. Okano,et al. Elucidation of the mechanism producing menaquinone-4 in osteoblastic cells. , 2009, Bioorganic & medicinal chemistry letters.
[4] P. Halbout,et al. Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response , 2009, Osteoporosis International.
[5] N. Amizuka,et al. Vitamin K2, a gamma-carboxylating factor of gla-proteins, normalizes the bone crystal nucleation impaired by Mg-insufficiency. , 2008, Histology and histopathology.
[6] M. Blostein,et al. Periostin, a Member of a Novel Family of Vitamin K-dependent Proteins, Is Expressed by Mesenchymal Stromal Cells* , 2008, Journal of Biological Chemistry.
[7] S. Kato,et al. Vitamin K Induces Osteoblast Differentiation through Pregnane X Receptor-Mediated Transcriptional Control of the Msx2 Gene , 2007, Molecular and Cellular Biology.
[8] M. McKee,et al. Endocrine Regulation of Energy Metabolism by the Skeleton , 2007, Cell.
[9] A. Zannettino,et al. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. , 2007, Bone.
[10] K. Horie-Inoue,et al. Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells. , 2007, Journal of molecular endocrinology.
[11] L. Schurgers,et al. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women , 2007, Osteoporosis International.
[12] pei-hsuan chu,et al. Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2 , 2006, Proceedings of the National Academy of Sciences.
[13] L. Bonewald,et al. Mechanism by which MLO-A5 Late Osteoblasts/Early Osteocytes Mineralize in Culture: Similarities with Mineralization of Lamellar Bone , 2006, Calcified Tissue International.
[14] C. Shanahan,et al. Molecular mechanisms mediating vascular calcification: Role of matrix Gla protein (Review Article) , 2006, Nephrology.
[15] E. Seeman,et al. Osteocytes—martyrs for integrity of bone strength , 2006, Osteoporosis International.
[16] S. Lanham-New,et al. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.
[17] K. Horie-Inoue,et al. Steroid and Xenobiotic Receptor SXR Mediates Vitamin K2-activated Transcription of Extracellular Matrix-related Genes and Collagen Accumulation in Osteoblastic Cells*♦ , 2006, Journal of Biological Chemistry.
[18] Stephen E. Harris,et al. E11/gp38 Selective Expression in Osteocytes: Regulation by Mechanical Strain and Role in Dendrite Elongation , 2006, Molecular and Cellular Biology.
[19] J. Iwamoto,et al. Effects of Vitamin K2 on the Development of Osteopenia in Rats as the Models of Osteoporosis , 2006, Yonsei medical journal.
[20] Y. Matsinos,et al. The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis , 2006, European Journal of Pediatrics.
[21] Kosaku Kurata,et al. Bone Marrow Cell Differentiation Induced by Mechanically Damaged Osteocytes in 3D Gel‐Embedded Culture , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[22] Christopher R. Jacobs,et al. Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading , 2006 .
[23] M. Mullender,et al. Mechanotransduction of bone cellsin vitro: Mechanobiology of bone tissue , 2006, Medical and Biological Engineering and Computing.
[24] K. Metsikkö,et al. Isolated primary osteocytes express functional gap junctions in vitro , 2006, Cell and Tissue Research.
[25] W. D. Clark,et al. Osteocyte Apoptosis and Osteoclast Presence in Chicken Radii 0–4 Days Following Osteotomy , 2005, Calcified Tissue International.
[26] J. Reeve,et al. The FASEB Journal express article 10.1096/fj.05-4221fje. Published online August 25, 2005. ©2005 FASEB , 2022 .
[27] D. Newitt,et al. Effects of Salmon Calcitonin on Trabecular Microarchitecture as Determined by Magnetic Resonance Imaging: Results From the QUEST Study , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[28] A. Zannettino,et al. Human trabecular bone‐derived osteoblasts support human osteoclast formation in vitro in a defined, serum‐free medium , 2005, Journal of cellular physiology.
[29] L. Suva,et al. Regulation of bone mass by mechanical loading: Microarchitecture and genetics , 2005, Current osteoporosis reports.
[30] A. Prentice,et al. Intake and sources of phylloquinone (vitamin K1) in 4-year-old British children: comparison between 1950 and the 1990s , 2005, Public Health Nutrition.
[31] D. Lamson,et al. Vitamin K2 in bone metabolism and osteoporosis. , 2005, Alternative medicine review : a journal of clinical therapeutic.
[32] K. Kurokawa,et al. Menatetrenone rescues bone loss by improving osteoblast dysfunction in rats immobilized by sciatic neurectomy. , 2005, Life sciences.
[33] M. Fukunaga,et al. Menaquinone-7 regulates the expressions of osteocalcin, OPG, RANKL and RANK in osteoblastic MC3T3E1 cells. , 2005, International journal of molecular medicine.
[34] E. Bonucci,et al. Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat , 2005, Journal of Molecular Histology.
[35] S. Kawai,et al. Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study. , 2004, The American journal of medicine.
[36] D. Howie,et al. The proliferation and phenotypic expression of human osteoblasts on tantalum metal. , 2004, Biomaterials.
[37] M. Takagi,et al. Differential Expression of Dentin Matrix Protein 1, Type I Collagen And Osteocalcin Genes in Rat Developing Mandibular Bone , 2001, The Histochemical Journal.
[38] M. Yamaguchi,et al. Stimulatory effect of menaquinone-7 (vitamim K2) on osteoblastic bone formation in vitro , 2001, Molecular and Cellular Biochemistry.
[39] J. Cassella,et al. An electron probe X-ray microanalytical study of bone mineral in osteogenesis imperfecta , 1995, Calcified Tissue International.
[40] B. Blumberg,et al. Vitamin K2 Regulation of Bone Homeostasis Is Mediated by the Steroid and Xenobiotic Receptor SXR* , 2003, Journal of Biological Chemistry.
[41] J. Iwamoto,et al. Combined treatment with vitamin k2 and bisphosphonate in postmenopausal women with osteoporosis. , 2003, Yonsei medical journal.
[42] A. Evdokiou,et al. RANKL Expression Is Related to the Differentiation State of Human Osteoblasts , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[43] P. Geusens,et al. Vitamin K1 Supplementation Retards Bone Loss in Postmenopausal Women Between 50 and 60 Years of Age , 2003, Calcified Tissue International.
[44] S. Yamamoto,et al. Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. , 2003, The Journal of endocrinology.
[45] L. Bonewald,et al. MLO‐Y4 Osteocyte‐Like Cells Support Osteoclast Formation and Activation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[46] T. Komori,et al. Dentin Matrix Protein 1 Is Predominantly Expressed in Chicken and Rat Osteocytes But Not in Osteoblasts , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[47] K. Hirokawa,et al. Expression Profiles of Receptor Activator of Nuclear Factor κB Ligand, Receptor Activator of Nuclear Factor κB, and Osteoprotegerin Messenger RNA in Aged and Ovariectomized Rat Bones , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[48] Y. Shibasaki,et al. Localization of receptor activator of NFkappaB ligand, RANKL, in periodontal tissues during experimental movement of rat molars. , 2001, Journal of electron microscopy.
[49] Y. Takeuchi,et al. Vitamin K(2) inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures. , 2000, Bone.
[50] J. Iwamoto,et al. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis , 2000, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.
[51] A. Hida,et al. Effect of vitamin K2 on osteoblast apoptosis: vitamin K2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine. , 2000, The Journal of laboratory and clinical medicine.
[52] T. Douchi,et al. A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy. , 1999, Maturitas.
[53] S. Gronthos,et al. Differential Cell Surface Expression of the STRO‐1 and Alkaline Phosphatase Antigens on Discrete Developmental Stages in Primary Cultures of Human Bone Cells , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[54] L. Bonewald,et al. Establishment of an Osteocyte‐like Cell Line, MLO‐Y4 , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[55] W. Webster,et al. Severe cervical dysplasia and nasal cartilage calcification following prenatal warfarin exposure. , 1997, American journal of medical genetics.
[56] S. Ham,et al. The mechanism of action of vitamin K. , 1995, Annual review of nutrition.
[57] P. Price,et al. Primary structure of bovine matrix Gla protein, a new vitamin K-dependent bone protein. , 1985, The Journal of biological chemistry.
[58] N. Ling,et al. Isolation and sequence of the vitamin K-dependent protein from human bone. Undercarboxylation of the first glutamic acid residue. , 1980, The Journal of biological chemistry.
[59] González-Rozas,et al. Endocrine regulation of energy metabolism by bone , 2022 .